miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line

por Kaur, Ramanpreet, Kanthaje, Shruthi, Taneja, Sunil, Dhiman, Radha K., Chakraborti, Anuradha
Publicado 2022

Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line

por Makol, Ankita, Kaur, Harpreet, Sharma, Sakshi, Kanthaje, Shruthi, Kaur, Ramanpreet, Chakraborti, Anuradha
Publicado 2020